Understanding how genetics and aging affect cancer risk and treatment.
Official title: Genetics, Epigenetics and Metabolism Research Program
Funded at University of Rochester · NIH-11014529 · Data updated 2026-11-12
This study is looking at how our genes and the way they change over time can affect aging and cancer, with the goal of finding better ways to prevent and treat cancer, so patients like you can have more options for care.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | March 15, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $37,440 |
| NIH project number | 1P30CA272302-01A1 |
| Project ID | NIH-11014529 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for cancer due to age or genetic predispositions.
✕Less likely to help
Patients with no genetic or age-related risk factors for cancer may not benefit from this research.
What this research studies
The Genetics, Epigenetics and Metabolism (GEM) program investigates the complex interactions between genetic and epigenetic factors that contribute to aging and cancer. By studying how aging influences cellular changes and vulnerabilities, researchers aim to uncover new therapeutic strategies for cancer treatment. The program involves collaboration among experts from various fields, fostering innovative approaches to understanding cancer biology. Patients may benefit from insights gained through this research, which could lead to improved cancer prevention and treatment options.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing and treating cancer by targeting the mechanisms of aging.
How similar studies have gone: Previous research has shown promising results in understanding the links between aging and cancer, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Vertino, Paula M. — University of Rochester
- Study coordinator: Vertino, Paula M.
Related research
Other NIH-funded projects on the same topics.
-
Rapid automated breast lump diagnosis without a radiologist or sonographer
A new AI-powered ultrasound tool helps determine if a palpable breast lump is likely benign or malignant, using a simplified technique that can be used by people with minimal ultrasound training.
-
ML-ROVER: Reducing Unneeded Lab Tests in Kids with AI
Aims to use machine learning to cut unnecessary blood tests in children in intensive care, helping avoid anemia and improve care quality.
-
Aggressive fever-reducing therapy to protect the brains of children with CNS malaria
A study planned for children with CNS malaria will test whether aggressive fever-reducing treatment can lower death and brain-related problems.
-
Aggressive fever-reducing therapy to protect brains in children with CNS malaria
A plan to test whether giving strong fever-reducing medications to children with central nervous system malaria can lower death and brain injury.
-
Aggressive fever-fighting treatment to protect the brain in kids with CNS malaria
A plan to test whether giving strong fever-reducing treatment alongside standard care can lower death and brain injury in children with CNS malaria.
-
Aggressive fever-reducing treatment to protect brains in kids with CNS malaria
A plan to test whether giving strong fever-reducing medicine alongside standard malaria treatment can lower deaths and brain injuries in children with CNS malaria.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.